| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions refers to medicine and aims at treating schizophrenia. A method of treating, preventing, delaying the progression or onset and/or development of schizophrenia involves administering an effective amount of a combined therapy containing dimebon and risperidone into the patient. A pharmaceutically acceptable composition for treating, preventing, delaying the progression or onset and/or development of schizophrenia contains dimebon and risperidone. A kit for treating, preventing, delaying the progression or onset and/or development of schizophrenia contains dimebon and risperidone, and a package leaflet. n EFFECT: using the declared group of inventions enables increasing the clinical effect of treating schizophrenia. n 7 cl |